Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

被引:0
|
作者
Xi-Ping Tang [1 ]
Guo-Du Tang [1 ]
Chun-Yun Fang [1 ]
Zhi-Hai Liang [1 ]
Lu-Yi Zhang [1 ]
机构
[1] Department of Gastroenterology,First Affiliated Hospital,Guangxi Medical University
基金
中国国家自然科学基金;
关键词
Ginsenoside Rh2; Human pancreatic cancer Bxpc-3 cell; Proliferation; Apoptosis; Migration;
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
AIM:To investigate the effects of ginsenoside Rh2 on the human pancreatic cancer cell line Bxpc-3.METHODS:The human pancreatic cancer cell line Bxpc-3 was cultured in vitro and treated with or without ginsenoside Rh2.Growth rates for Bxpc-3 cells were assessed by methyl thiazolyl tetrazolium(MTT) and colony formation assays.Cell cycle changes were analyzed by flow cytometry.Apoptosis was measured by flow cytometry and Hoechst 33258 fluorescence staining.A scratch assay and a Matrigel invasion assay were used to detect cell migration and invasion.Expression of Bax,Bcl-2,survivin,cyclin D1,matrix metalloproteinase(MMP)-2,MMP-9,cleaved caspase-3,caspase-8,and caspase-9 mRNA were determined by reverse transcriptase-polymerase chain reaction(RT-PCR).Bax,Bcl-2,survivin,cyclin D1,cleaved caspase-3,caspase-8 and caspase-9 protein levels were examined by western blotting.Expression of MMP-2 and MMP-9 proteins in culture supernatants were determined by enzymelinked immunosorbent assay(ELISA).RESULTS:Rh2 significantly inhibited Bxpc-3 cell proliferation in a dose-and time-dependent manner,as evaluated by the MTT(P < 0.05) and colony formation assays(P < 0.05).Compared to the control group,Rh2 significantly increased the percentage of Bxpc-3 cells in the G 0 /G 1 phase from 43.32% ± 2.17% to 71.32% ± 1.16%,which was accompanied by a decrease in S phase(from 50.86% ± 1.29% to 28.48% ± 1.18%) and G 2 /M phase(from 5.81% ± 1.19% to 0.20% ± 0.05%) in a dose-dependent manner(P < 0.05),suggesting that Rh2 arrested cell cycle progression at the G 0 /G 1 phase,as measured by flow cytometry.Compared to the control group,cells treated with Rh2 showed significantly higher apoptosis ratios in a dosedependent manner(percentage of early apoptotic cells:from 5.29% ± 2.28% to 38.90% ± 3.42%(F = 56.20,P < 0.05);percentage of late apoptotic cells:from 4.58% ± 1.42% to 36.32% ± 2.73%(F = 86.70,P < 0.05).Rh2 inhibited Bxpc-3 cell migration and invasion,as detected by scratch wound healing assay and Matrigel invasion assay [percentages of scratch wound healing for 12 h,24 h and 48 h(control vs experimental group):37.3% ± 4.8%vs 18.30% ± 1.65%,58.7% ± 3.5% vs 38.00% ± 4.09% and 93.83% ± 4.65% vs 65.50% ± 4.09%,respectively;t = 6.489,t = 6.656 and t = 7.926,respectively,P < 0.05;the number of cells invading at various concentrations(0 μmol/L,35 μmol/L,45 μmol/L and 55 μmol/L):81.10 ± 9.55,46.40 ± 6.95,24.70 ± 6.88 and 8.70 ± 3.34,respectively(F = 502.713,P < 0.05)].RT-PCR,western blotting or ELISA showed that mRNA and protein expression of Bax,cleaved caspase-3 and caspase-9 were upregulated(P < 0.05),while mRNA and protein expression of Bcl-2,survivin,cyclin D1,MMP-2 and MMP-9 were downregulated(P < 0.05).CONCLUSION:Ginsenoside Rh2 inhibits proliferation,migration and invasion and induces apoptosis of the human pancreatic cancer cell line Bxpc-3.
引用
收藏
页码:1582 / 1592
页数:11
相关论文
共 50 条
  • [21] Preparation and Inhibitory Effects of 20(S)-Ginsenoside Rh2 on Hep-A-22 Cells
    ZHOU Hong-yu~1
    2.Basic Medical School
    ChemicalResearchinChineseUniversities, 2010, 26 (04) : 567 - 571
  • [22] Identification of cellular targets for ginsenoside Rh2
    Wang, Yu-Shi
    Jin, Ying-Hua
    Lin, Yingjia
    Li, He
    CANCER SCIENCE, 2018, 109 : 365 - 365
  • [23] Antimicrobial effects of the ginsenoside Rh2 on monospecies and multispecies cariogenic biofilms
    Cao, X.
    Ye, Q.
    Fan, M.
    Liu, C.
    JOURNAL OF APPLIED MICROBIOLOGY, 2019, 126 (03) : 740 - 751
  • [24] EGFR signaling-dependent inhibition of glioblastoma growth by ginsenoside Rh2
    Li, Shaoyi
    Gao, Yun
    Ma, Weining
    Guo, Wenchang
    Zhou, Gang
    Cheng, Tianci
    Liu, Yunhui
    TUMOR BIOLOGY, 2014, 35 (06) : 5593 - 5598
  • [25] Ginsenoside Rh2 and Rh3 induce differentiation of HL-60 cells into granulocytes:: modulation of protein kinase C isoforms during differentiation by ginsenoside Rh2
    Kim, YS
    Kim, DS
    Kim, SI
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1998, 30 (03): : 327 - 338
  • [26] Ginsenoside Rh2 Inhibits Cancer Stem-Like Cells in Skin Squamous Cell Carcinoma
    Liu, Shunli
    Chen, Mingrui
    Li, Pengcheng
    Wu, Yujia
    Chang, Chunjuan
    Qiu, Yabin
    Cao, Ling
    Liu, Zhen
    Jia, Chiyu
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 36 (02) : 499 - 508
  • [27] Reversal effect of ginsenoside Rh2 on oxaliplatin-resistant colon cancer cells and its mechanism
    Ma, Jun
    Gao, Guangyi
    Lu, Hong
    Fang, Dong
    Li, Lingchang
    Wei, Guoli
    Chen, Aifei
    Yang, Yong
    Zhang, Hongying
    Huo, Jiege
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (01) : 630 - 636
  • [28] Anticancer property of ginsenoside Rh2 from ginseng
    Li, Xun
    Chu, Shifeng
    Lin, Meiyu
    Gao, Yan
    Liu, Yingjiao
    Yang, Songwei
    Zhou, Xin
    Zhang, Yani
    Hu, Yaomei
    Wang, Huiqin
    Chen, Naihong
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [29] Treatment of Stress Urinary Incontinence by Ginsenoside Rh2
    Chen, Yung-Hsiang
    Lin, Yu-Ning
    Chen, Wen-Chi
    Hsieh, Wen-Tsong
    Chen, Huey-Yi
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2014, 42 (04): : 817 - 831
  • [30] Potential of ginsenoside Rh2 and its derivatives as anti-cancer agents
    Li, Keke
    Li, Zhongyu
    Men, Lei
    Li, Wei
    Gong, Xiaojie
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (12) : 881 - 901